Feed ABBV.BA
AB

AbbVie Inc.

ABBV.BA · BUE

43,000.00 $ +0.47% (+200.00 $)
1M +1.96%
Market Cap $496.7B
P/E Ratio 90.20x
Div. Yield 0.60%
ROE -

Bulios Fair Price

33,283 $

22.6% downside

Current Price

43,000 $

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ABBV.BA is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong
8/9
Valuation
16 /100
Expensive
P/E 90.20x
EV/EBITDA 29.75x
P/S 7.80x
Growth
1 /100
Declining
EPS growth 31.73%
Rev. growth 3.31%
FCF growth 14.25%
Profitability
92 /100
Strong
Gross margin 76.94%
Net margin 8.64%
Op. margin 33.02%
Quality
62 /100
Average
ROIC 14.39%
ROA 4.11%
Asset turnover 0.48x
Debt
40 /100
Moderate
Current ratio 0.81x
Int. coverage 5.45x
Net debt/EBITDA 3.38x
Stability
71 /100
Stable
Beta 0.28x
Rev. volatility 5.98%
EPS volatility 27.31%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ABBV.BA
Online

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Robert A. Michael

Employees

57,000

Headquarters

North Chicago

Upcoming events

15 OCT

Ex-Dividend

Ex-dividend date

9d
16 NOV

Dividend Payment

Payment date

41d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.